Stocksigma LogoStocksigma Logo

Aurobindo Pharma Approves Merger of Wholly Owned API Subsidiaries

Aurobindo Pharma鈥檚 board approved a Scheme of Amalgamation to merge its wholly owned subsidiary Auroactive Pharma (FY26 turnover: INR 701.3m) into Apitoria

Aurobindo Pharma Approves Merger of Wholly Owned API Subsidiaries

Aurobindo Pharma Ltd 路 Others (Uncategorized) 路 05 Nov 2026, 1:58 am

Aurobindo Pharma Approves Merger of Wholly Owned API Subsidiaries Aurobindo Pharma鈥檚 board approved a Scheme of Amalgamation to merge its wholly owned subsidiary Auroactive Pharma (FY26 turnover: INR 701.3m) into Apitoria Pharma (FY26 turnover: INR 64,430.8m), subject to NCLT Hyderabad approval. The swap ratio is set at 97 equity shares of Apitoria Pharma for every 10,000 shares of Auroactive Pharma, totaling 2,395,900 shares. The consolidation aims to integrate API operations, optimize capacity utilization, and simplify group structure, with no change to the parent company's shareholding pattern.

Original exchange filing (PDF)

More announcements from Aurobindo Pharma Ltd

All Aurobindo Pharma Ltd announcements